Research
-
To find giant black holes, start with Jupiter
On a quest to find the Universe’s largest black holes, Vanderbilt researcher identifies the center of the solar system within 100 meters. Read MoreJun 30, 2020
-
Enhanced e-book helps close the word gap in children from families of low socio-economic status
New research from Vanderbilt Peabody College of education and human development asks whether the use of an enhanced electronic book can train parents in reading methods that facilitate parent-child conversations, which are known to spur preschool vocabulary development and the language processing skills necessary to close the word gap. Read MoreJun 29, 2020
-
Nine faculty receive 2020 Research Scholar and Discovery grants
Research Scholar Grants are one of Vanderbilt’s primary investments to advance faculty research, scholarship and creative expression, while Discovery Grants support new ideas and cutting-edge scholarship that possess high potential for future external support. Read MoreJun 29, 2020
-
NPEF, Peabody to host virtual conversation on dismantling inequities among Nashville youth June 30
The Nashville Public Education Foundation and Vanderbilt Peabody College will host a free webinar, “A City Where All Youth Thrive: A Conversation about Dismantling the Inequities of the Nashville Youth Experience,” on Tuesday, June 30, from 4 to 5 p.m. CT. Read MoreJun 26, 2020
-
International collaboration draws new conclusions about ‘convergent evolution’ of saber-tooth cats
International collaboration shows that marsupial saber-tooth cats were more closely related to possums than fearsome predators. Read MoreJun 26, 2020
-
VISE researchers receive $3.1M grant for customizable cochlear implant programming
A team of Vanderbilt University and Vanderbilt University Medical Center researchers has received a $3.1 million NIH grant to develop advanced patient-specific cochlear implant stimulation models for customized implant programming. Read MoreJun 26, 2020
-
VICTR named to key role to streamline COVID-19 research response
The Vanderbilt Institute for Clinical and Translational Research (VICTR), which provides comprehensive support for clinical and translational research at Vanderbilt University Medical Center (VUMC), has been named Administrative Coordinating Center (ACC) of a national effort to streamline the research response to life-threatening lung and heart problems caused by COVID-19. Read MoreJun 24, 2020
-
Study shows better option for treatment of inoperable anal cancer
People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered. Read MoreJun 24, 2020
-
Data Science Institute big data model to help Monroe Carell Jr. Children’s Hospital prepare for patient needs during pandemic and beyond
Vanderbilt's Data Science Institute researchers are developing a model to use big data to address the impact of COVID-19 on policies, procedures, and resources now and in the future. The tool will help Monroe Carell Jr. Children's Hospital at Vanderbilt evaluate short- and long-term resource needs in order to be fully prepared to meet patients' needs. Read MoreJun 24, 2020
-
Discovery of aggressive cancer cell types by Vanderbilt researchers made possible with machine learning techniques
Rebecca Ihrie and Jonathan Irish are leading the development of machine learning applications for brain cancer research. Read MoreJun 24, 2020
-
Vanderbilt astronomers among NASA’s TESS Mission team to discover a rare newly formed planet
Stars mapped out by Vanderbilt astronomers for exploration by NASA’s Transiting Exoplanet Survey Satellite mission and recently decommissioned Spitzer Space Telescope have led to the discovery of AU Mic b, a newly formed Neptune-like exoplanet located a relatively short 31.9 light-years away. Read MoreJun 24, 2020
-
Study finds zinc doesn’t reduce mortality, other health risks, for heavy alcohol users living with HIV/AIDS
Zinc supplementation did not reduce mortality, cardiovascular risk, levels of inflammation or microbial translocation among people with heavy alcohol use living with HIV/AIDS, according to a Vanderbilt-led study. Read MoreJun 24, 2020
-
Glaucoma drug studied to prevent lung Infection in COVID-19 patients
Vanderbilt University Medical Center is evaluating razuprotafib, a drug used to treat glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19. Read MoreJun 24, 2020
-
Vanderbilt partnership with Nashville Ballet examines changing ideas of masculinity and gender
A spring 2020 seminar immersed Vanderbilt students in a unique academic experience examining gender stereotypes, masculinity and identity through the lens of dance as part of a special partnership between Nashville Ballet and the university. Read MoreJun 24, 2020
-
A connection to schizophrenia
The insula, a small region of the brain involved in diverse brain functions had widespread dysconnectivity in schizophrenia, Vanderbilt researchers found. Read MoreJun 23, 2020
-
Limited Submission Opportunity: 2020 TD Ready Challenge–Innovative COVID-19 Solutions
The Toronto-Dominion Bank Ready Challenge will fund grants of up to $1 million (CAD) to provide innovative solutions that address the impacts of the COVID-19 pandemic, specifically for communities that are experiencing disproportionate impacts of COVID-19. Read MoreJun 22, 2020
-
Single mutation causes seizure disorder
A single mutation in one gene can impair inhibitory signaling in the brain and cause multiple types of seizures and behavioral abnormalities. Read MoreJun 22, 2020
-
Vanderbilt Phase 2 of Return to Campus Plan remains in place as Nashville begins Phase 3
While Nashville will enter the third phase of its Roadmap for Reopening beginning Monday, June 22, Vanderbilt University will continue to follow its own Return to Campus Plan, which is currently in Vanderbilt Phase 2. Read MoreJun 22, 2020
-
Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19
The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm. Read MoreJun 21, 2020
-
Vanderbilt defines the pathways for solid-state battery development
Vanderbilt researcher Kelsey Hatzell leads the discussion on the future of solid-state batteries. Read MoreJun 19, 2020